Bevacizumab in Combination With Verteporfin Reduced and Standard Fluence in the Treatment of Hemorrhaged Lesions in Neovascular AMD
Clinical trial NCT00403442 · TERMINATED
Trial details
- NCT number
- NCT00403442
- Sponsor
- Vitreous -Retina- Macula Consultants of New York
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.